Vascular Biogenics Ltd.

Q2 2016 vs. Q3 2020 13F Holders

Period
Q2 2016
Q3 2020
Num holders
28
16
Total reported value, excl. options
$19.4 M
$2.30 M
Total shares, excl. options
4,211,168
1,890,501
Manager Q2 2016
Shares
Q3 2020
Shares
Diff Chg %